Income Statement

v3.6.0.2
Consolidated Statements of Operations - USD ($)
3 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenues:    
Chronic illness monitoring supplies revenues $ 1,608,074 $ 1,853,417
Chronic illness monitoring fee revenues 253,520 234,253
Total Chronic illness monitoring revenues 1,861,594 2,087,670
Cost of revenues:    
Chronic illness monitoring supplies cost of revenues 1,199,158 1,464,850
Chronic illness monitoring fee cost of revenues 100,992 128,506
Total Chronic illness monitoring cost of revenues 1,300,150 1,593,356
Gross profit 561,444 494,314
Operating expenses:    
Selling, general and administrative (including $11,953 and $1,179,922, respectively, of stock-based compensation) 1,210,295 2,346,705
Research and development 167,608 22,909
Total operating expenses 1,377,903 2,369,614
Loss from operations (816,459) (1,875,300)
Other income (expense):    
Gain on derivatives liability 22,057 46,311
Gain on disposal of property and equipment   600
Interest expense, net (1,555,416) (491,149)
Loss on extinguishment of debt (2,004,218)  
Total other expense (3,537,577) (444,238)
Net loss (4,354,036) (2,319,538)
Dividends on preferred stock (34,178) (403,548)
Net loss attributable to common stockholders $ (4,388,214) $ (2,723,086)
Net loss per common share - basic and diluted $ (18.91) $ (17.27)
Weighted average common shares outstanding - basic and diluted 232,100 157,652

Source